MedPath

Sodium citrate

Generic Name
Sodium citrate
Brand Names
As 3, Bss, Bss Ophthalmic Solution, Cpda-1 Blood Collection System, Dalmacol, EnLyte, Intersol, Leukotrap, Nauzene, Oracit, Tricitrasol
Drug Type
Small Molecule
Chemical Formula
C6H5Na3O7
CAS Number
68-04-2
Unique Ingredient Identifier
RS7A450LGA

Overview

Sodium citrate is the sodium salt of citric acid. It is white, crystalline powder or white, granular crystals, slightly deliquescent in moist air, freely soluble in water, practically insoluble in alcohol. Like citric acid, it has a sour taste. From the medical point of view, it is used as alkalinizing agent. It works by neutralizing excess acid in the blood and urine. It has been indicated for the treatment of metabolic acidosis.

Background

Sodium citrate is the sodium salt of citric acid. It is white, crystalline powder or white, granular crystals, slightly deliquescent in moist air, freely soluble in water, practically insoluble in alcohol. Like citric acid, it has a sour taste. From the medical point of view, it is used as alkalinizing agent. It works by neutralizing excess acid in the blood and urine. It has been indicated for the treatment of metabolic acidosis.

Indication

Used as an anticoagulant during plasmophoresis as well as a neutralizing agent in the treatment of upset stomach and acidic urine .

Associated Conditions

  • Acidosis
  • Allergic Reaction
  • Allergic cough
  • Asthma
  • Asthma Chronic, Cough
  • Common Cold
  • Cough
  • Coughing caused by Bronchitis
  • Dehydration
  • Gout
  • Heartburn
  • Metabolic Acidosis
  • Phlegm

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Haemonetics Manufacturing Inc
53157-796
INTRAVENOUS
2.20 g in 100 mL
2/9/2015
Pharmaceutical Associates, Inc.
0121-0595
ORAL
500 mg in 5 mL
12/15/2022
Maco Productions
14498-005
INTRAVENOUS
0.92 g in 35 mL
8/14/2021
Maco Productions
14498-004
INTRAVENOUS
0.76 g in 29 mL
12/21/2017
PAI Holdings, LLC
0121-0677
ORAL
500 mg in 5 mL
4/10/2023
Haemonetics Corporation
53157-736
INTRAVENOUS
1.66 g in 63 mL
7/19/2023
Chartwell RX, LLC
62135-434
ORAL
500 mg in 5 mL
10/5/2023
Global Life Sciences Solutions USA LLC
79403-791
INTRAVENOUS
0.921 g in 35 mL
12/20/2023
ATLANTIC BIOLOGICALS CORP.
17856-0677
ORAL
500 mg in 5 mL
9/26/2018
Haemonetics Manufacturing Inc
53157-798
INTRAVENOUS
10.0 g in 250 mL
2/9/2015

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
HOVA EXPECTORANT
SIN03251P
SYRUP
57 mg/5 ml
6/12/1989
SEMERIN COUGH SYRUP
SIN03526P
SYRUP
150 mg/5 ml
5/25/1989
REGIOCIT SOLUTION FOR HAEMOFILTRATION
SIN15513P
SOLUTION, STERILE
5.29 g/l
7/19/2018
MINICA S ENEMA
SIN03514P
ENEMA
9% w/w
6/15/1989
SW BENA-EXPECTORANT
SIN02911P
SYRUP
46 mg/5 ml
5/22/1989
SW-BENA PAEDIATRIC EXPECTORANT
SIN07609P
SYRUP
50 mg/5 ml
1/14/1994
Ural Effervescent Granules
SIN14374P
GRANULE, EFFERVESCENT
0.63g
6/26/2013
XSP-BENA EXPECTORANT
SIN03335P
SUSPENSION
57.5 mg/5 ml
6/16/1989

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Sodium Citrate Injection for Transfusion
国药准字H20153149
化学药品
注射剂
5/9/2020
Sodium Citrate Injection for Transfusion
国药准字H37022699
化学药品
注射剂
5/7/2020
Sodium Citrate Injection for Transfusion
国药准字H20013323
化学药品
注射剂
5/7/2020
Hemofiltration Replacement Fluid of Sodium Citrate
国药准字H20253005
化学药品
注射剂
1/2/2025
Hemofiltration Replacement Fluid of Sodium Citrate
国药准字H20253505
化学药品
注射剂
3/4/2025
Hemofiltration Replacement Fluid of Sodium Citrate
国药准字HJ20210035
化学药品
注射剂
5/19/2021
Sodium Citrate Injection for Anticoagulant
国药准字H20043967
化学药品
注射剂
9/30/2020
Sodium Citrate Injection for Anticoagulant
国药准字H20055065
化学药品
注射剂(注射液)
7/13/2020
Sodium Citrate Injection for Anticoagulant
国药准字H20073118
化学药品
注射剂(注射液)
7/13/2020
Sodium Citrate Injection for Anticoagulant
国药准字H31020830
化学药品
注射剂
4/7/2024

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
DIPHENMIN EXPECTORANT
N/A
N/A
N/A
4/27/1979
U-BANOL "S" EXPECTORANT
N/A
synco (h.k.) limited
N/A
N/A
4/20/1979
GUSILON COUGH LINCTUS
N/A
karen laboratories o/b karen pharmaceutical co ltd
N/A
N/A
5/17/1982
NA-DRAMINE EXPECTORANT (BROWN)
N/A
national pharmaceutical co ltd
N/A
N/A
5/3/1979
MIST EXPECT STIM
N/A
N/A
N/A
2/25/1984
REGIOCIT SOLUTION FOR HAEMOFILTRATION
N/A
N/A
N/A
8/11/2017
DIPHENHYDRAMINE COMPOUND LINCTUS
N/A
N/A
N/A
4/30/1998
CORY SYRUP
N/A
neochem pharmaceutical laboratories ltd.
N/A
N/A
4/27/1979
BANOLIN EXPECTORANT
N/A
unicorn laboratories o/b american unicorn laboratories limited
N/A
N/A
1/7/1984
BENYL EXPECTORANT SYRUP
N/A
N/A
N/A
4/14/1987
© Copyright 2025. All Rights Reserved by MedPath